These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 12407484)

  • 1. Considerations on the associations between antiretroviral regimen and changes in blood pressure in the D2EFT study.
    Martinez E
    Clin Infect Dis; 2024 Jun; ():. PubMed ID: 38943371
    [No Abstract]   [Full Text] [Related]  

  • 2. Healthcare Resource Consumption and Related Costs in Patients on Antiretroviral Therapies: Findings from Real-World Data in Italy.
    Perrone V; Dovizio M; Sangiorgi D; Andretta M; Bartolini F; Cavaliere A; Ciaccia A; Chinellato A; Costantini A; Dell'Orco S; Ferrante F; Gentile S; Lavalle A; Moscogiuri R; Mosele E; Procacci C; Re D; Santoleri F; Roccia A; Maggiolo F; Degli Esposti L
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36900813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial Correlates of Medication Adherence among HIV-Positive, Cognitively Impaired Individuals.
    Arentsen TJ; Panos S; Thames AD; Arbid JN; Castellon SA; Hinkin CH
    J HIV AIDS Soc Serv; 2016; 15(4):404-416. PubMed ID: 28713226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network.
    Wolff M; Shepherd BE; Cortés C; Rebeiro P; Cesar C; Wagner Cardoso S; Pape JW; Padgett D; Sierra-Madero J; Echevarria J; McGowan CC;
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):102-10. PubMed ID: 26761273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive, academic, and behavioral correlates of medication adherence in children and adolescents with perinatally acquired HIV infection.
    Nichols SL; Montepiedra G; Farley JJ; Sirois PA; Malee K; Kammerer B; Garvie PA; Naar-King S;
    J Dev Behav Pediatr; 2012 May; 33(4):298-308. PubMed ID: 22366661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral treatment regimen outcomes among HIV-infected prisoners.
    Springer SA; Friedland GH; Doros G; Pesanti E; Altice FL
    HIV Clin Trials; 2007; 8(4):205-12. PubMed ID: 17720660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switch strategies in antiretroviral therapy regimens.
    Van den Eynde E; Podzamczer D
    Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1055-74. PubMed ID: 25075752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical and conceptual challenges in measuring antiretroviral adherence.
    Berg KM; Arnsten JH
    J Acquir Immune Defic Syndr; 2006 Dec; 43 Suppl 1(Suppl 1):S79-87. PubMed ID: 17133207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of antiretroviral regimen switches on adherence.
    Miller LG; Golin CE; Hays RD; Liu H; Beck CK; Kaplan AH; Wenger NS
    HIV Clin Trials; 2002; 3(5):355-60. PubMed ID: 12407484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lopinavir/ritonavir-based once-daily regimen results in better compliance and is non-inferior to a twice-daily regimen through 96 weeks.
    Molina JM; Podsadecki TJ; Johnson MA; Wilkin A; Domingo P; Myers R; Hairrell JM; Rode RA; King MS; Hanna GJ
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1505-14. PubMed ID: 18160008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study.
    Martin M; Del Cacho E; Codina C; Tuset M; De Lazzari E; Mallolas J; Miró JM; Gatell JM; Ribas J
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1263-8. PubMed ID: 18834323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy.
    Mathews WC; Mar-Tang M; Ballard C; Colwell B; Abulhosn K; Noonan C; Barber RE; Wall TL
    AIDS Patient Care STDS; 2002 Apr; 16(4):157-72. PubMed ID: 12015870
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.